PubMed Health⌕ Search

Biomedical subjects

Stephen Anthony

Publications and source records attributed to Stephen Anthony.

2 recordsLinked to original sources

Methods to track single-molecule trajectories.

Methods are discussed to track single molecules in planar-supported phospholipid bilayers. Mainly, these methods constitute optimizations for a low signal-to-noise ratio and for the dim optical characteristics of single molecules. Algorithmic modifications to compensate and correct for misidentifications and misassignments are also described. One key advance, which exchanges the typically fragmented reconstruction of the molecules' motion for more complete trajectories, is the incorporation of information about the molecules' past and future positions into the tracking. Although the main point of these methods is to aid in extending methods of object tracking to the single-molecule regime, they may also find use in other situations where the signal-to-noise ratio is low.

Journal Article↗

Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer.

L523S is an immunogenic lung cancer antigen that has demonstrated preclinical safety when the gene is injected intramuscularly as an expressive plasmid (pVAX/L523S) and when delivered following incorporation into an E1B-deleted adenovirus (Ad/L523S). We performed a phase I clinical trial in 13 stage IB, IIA, and IIB non-small-cell lung cancer patients. pVAX/L523S (8 mg on days 0 and 14 in all cohorts) and Ad/L523S (1, 20, 400 x 10(9) vp on days 28 and 56, cohorts 1, 2, and 3, respectively) were administered to 3 patients in each of three cohorts. No significant toxic effect was identified. All but 1 patient demonstrated greater than or equal to twofold elevation in anti-adenovirus antibodies. One of 10 evaluable patients demonstrated L523S-specific antibody by direct IgG ELISA. Two patients developed disease recurrence and all remain alive after a median of 290 days follow-up. Results suggest a high level of safety but evidence of L523S-directed immune activation was limited, suggesting a need for modification of dose, schedule, and site of vaccination (i.e., intradermal) with further clinical testing.

Adenoviridae↗